Filing Details
- Accession Number:
- 0001104659-22-064008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-23 21:00:33
- Reporting Period:
- 2022-05-20
- Accepted Time:
- 2022-05-23 21:00:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1621227 | Adaptimmune Therapeutics Plc | ADAP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1577539 | Gavin Wood | C/O Adaptimmune Therapeutics Plc, 60 Jubilee Avenue, Milton Park Abingdon X0 OX14 4RX | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares With A Nominal Value Of Gbp0.001 Per Share | Acquisiton | 2022-05-20 | 39,000 | $0.29 | 96,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The ordinary shares whose purchase is reported on this line are represented by American Depositary Shares ("ADS") and are held in the form of ADSs by Gavin Wood. Each ADS represents six ordinary shares of Adaptimmune Therapeutics plc.
- The 39,000 ordinary shares reported in Column 4 are represented by 6,500 ADSs.
- The price reported in Column 4 of $0.2904 per ordinary share is derived from the purchase price paid on May 20, 2022 of $1.7423 per ADS divided by six.
- The 96,000 ordinary shares reported in Column 5 include 57,000 ordinary shares represented by 9,500 ADSs owned by Mr. Wood prior to the purchase reported in Column 4. These shares are held in the form of ADSs by Mr. Wood.
Billionaire Hedge Funds
